Literature DB >> 20005010

Do emergency physicians attribute drug-related emergency department visits to medication-related problems?

Corinne M Hohl1, Peter J Zed, Jeffrey R Brubacher, Riyad B Abu-Laban, Peter S Loewen, Roy A Purssell.   

Abstract

STUDY
OBJECTIVE: Adverse drug events represent the most common cause of preventable nonsurgical adverse events in medicine but may remain undetected. Our objective is to determine the proportion of drug-related visits emergency physicians attribute to medication-related problems.
METHODS: This prospective observational study enrolled adults presenting to a tertiary care emergency department (ED) during 12 weeks. Drug-related visits were defined as ED visits caused by adverse drug events. The definition of adverse drug event was varied to examine both narrow and broad adverse drug event classification systems. Clinical pharmacists evaluated all patients for drug-related visits, using standardized assessment algorithms, and then followed patients until hospital discharge. Interrater agreement for the clinical pharmacist diagnosis of drug-related visit was assessed. Emergency physicians, blinded to the clinical pharmacist opinion, were interviewed at the end of each shift to determine whether they attributed the visit to a medication-related problem. An independent committee reviewed and adjudicated all cases in which the emergency physicians' and clinical pharmacists' assessments were discordant, or either the emergency physician or clinical pharmacist was uncertain. The primary outcome was the proportion of drug-related visits attributed to a medication-related problem by emergency physicians.
RESULTS: Nine hundred forty-four patients were enrolled, of whom 44 patients received a diagnosis of the narrowest definition of an adverse drug event, an adverse drug reaction (4.7%; 95% confidence interval [CI] 3.5% to 6.2%). Twenty-seven of these were categorized as medication-related by emergency physicians (61.4%; 95% CI 46.5% to 74.3%), 10 were categorized as uncertain (22.7%; 95% CI 12.9% to 37.1%), and 7 categorized as a non-medication-related problem (15.9%; 95% CI 8.0% to 29.5%). Seventy-eight patients (8.3%; 95% CI 6.7% to 10.2%) received a diagnosis of an adverse drug event caused by an adverse drug reaction, a drug interaction, drug withdrawal, a medication error, or noncompliance. Emergency physicians attributed 49 of these to a medication-related problem (62.8%; 95% CI 51.7% to 72.7%), were uncertain about 15 (19.2%; 95% CI 12.0% to 29.4%), and attributed 14 to non-medication-related problems (17.9%; 95% CI 11.0% to 27.9%). Twenty-five of 29 (86.2%; 95% CI 69.3% to 94.4%) adverse drug events not considered medication related by emergency physicians were rated at least moderate in severity.
CONCLUSION: A significant proportion of drug-related visits are not deemed medication related by emergency physicians. Drug-related visits not attributed to medication-related problems by emergency physicians may be missed in ongoing outpatient adverse drug event surveillance programs intended to develop strategies to enhance drug safety. Further research is needed to determine what the effect may be of not attributing adverse drug events to medication-related problems. Copyright (c) 2009 American College of Emergency Physicians. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20005010     DOI: 10.1016/j.annemergmed.2009.10.008

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  36 in total

1.  Medication Reconciliation Practices in Canadian Emergency Departments: A National Survey.

Authors:  Richard Wanbon; Catherine Lyder; Eric Villeneuve; Stephen Shalansky; Leslie Manuel; Melanie Harding
Journal:  Can J Hosp Pharm       Date:  2015 May-Jun

2.  Application of the Pareto principle to identify and address drug-therapy safety issues.

Authors:  Fabian Müller; Harald Dormann; Barbara Pfistermeister; Anja Sonst; Andrius Patapovas; Renate Vogler; Nina Hartmann; Bettina Plank-Kiegele; Melanie Kirchner; Thomas Bürkle; Renke Maas
Journal:  Eur J Clin Pharmacol       Date:  2014-03-21       Impact factor: 2.953

3.  The effect of pharmacist-led medication review in high-risk patients in the emergency department: an evaluation protocol.

Authors:  Corinne M Hohl; Kimberlyn McGrail; Boris Sobolev
Journal:  CMAJ Open       Date:  2015-01-13

4.  Performance of trigger tools in identifying adverse drug events in emergency department patients: a validation study.

Authors:  Andrei Karpov; Catherine Parcero; Catherine P Y Mok; Chandima Panditha; Eugenia Yu; Linda Dempster; Corinne M Hohl
Journal:  Br J Clin Pharmacol       Date:  2016-07-08       Impact factor: 4.335

5.  Emergency Department Visits for Adverse Drug Reactions Involving Alcohol: United States, 2005 to 2011.

Authors:  I-Jen P Castle; Chuanhui Dong; Sarah P Haughwout; Aaron M White
Journal:  Alcohol Clin Exp Res       Date:  2016-08-04       Impact factor: 3.455

6.  The Role of Clinical Pharmacists in the Emergency Department.

Authors:  Brenna M Farmer; Bryan D Hayes; Rama Rao; Natalija Farrell; Lewis Nelson
Journal:  J Med Toxicol       Date:  2017-10-26

7.  Mortality among patients due to adverse drug reactions that lead to hospitalization: a meta-analysis.

Authors:  Tejas K Patel; Parvati B Patel
Journal:  Eur J Clin Pharmacol       Date:  2018-03-19       Impact factor: 2.953

8.  Adverse events associated with hospitalization or detected through the RAI-HC assessment among Canadian home care clients.

Authors:  Diane Doran; John P Hirdes; Régis Blais; G Ross Baker; Jeff W Poss; Xiaoqiang Li; Donna Dill; Andrea Gruneir; George Heckman; Hélène Lacroix; Lori Mitchell; Maeve O'Beirne; Andrea Foebel; Nancy White; Gan Qian; Sang-Myong Nahm; Odilia Yim; Lisa Droppo; Corrine McIsaac
Journal:  Healthc Policy       Date:  2013-08

9.  Implementing a clinical pharmacy survey of adverse drug events in a French emergency department.

Authors:  Lucien Roulet; Nathalie Asseray; Martin Dary; Anne Chiffoleau; Gilles Potel; Françoise Ballereau
Journal:  Int J Clin Pharm       Date:  2012-08-25

10.  Receipt of high risk medications among elderly enrollees in Medicare Advantage plans.

Authors:  Danya M Qato; Amal N Trivedi
Journal:  J Gen Intern Med       Date:  2012-11-06       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.